![Scaling Enterprise Finance: The Future of Biofuels](/sites/default/files/styles/search_thumbnail/public/2022-02/Screen%20Shot%202022-02-16%20at%2012.27.02%20PM.png?itok=JG5WF8jj)
Scaling Enterprise Finance: The Future of Biofuels
![Financing the Residential RetRoFit Revolution](/sites/default/files/styles/search_thumbnail/public/2022-02/Financing%20the%20Residential%20Retrofit%20Revolution_FIL_Report%20Cover.png?itok=_hMALUjf)
Financing the Residential RetRoFit Revolution
![Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing](/sites/default/files/oembed_thumbnails/uhv6_5STs2dr2JslkZy8v6kzZr-pKjxIqNXb_FhZVi4.jpg)
Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing
![Panel - Mental Health: Research and Development at a Crossroads](/sites/default/files/oembed_thumbnails/mwlnR6-1fq1RG9pzXHZ_253j7mshDWmTtmMCb23OJKk.jpg)
Panel - Mental Health: Research and Development at a Crossroads
![Health Reform II: Where Do We Go From Here?](/sites/default/files/oembed_thumbnails/RaU_XAHIJ9pxnnt6XK0Kf1BVsvHmDpbJvi-oX0WAy9A.jpg)
Health Reform II: Where Do We Go From Here?
![Rethinking Financing for Global Health](/sites/default/files/oembed_thumbnails/8lmeuspLTvhFAxNmH5COgGSY7omzfjd0dod7f1aueRg.jpg)
Rethinking Financing for Global Health
![Plenary: Five People Changing the Face of Bioscience](/sites/default/files/oembed_thumbnails/Ov7iJRkl4Bc27xyqqnuLHg_7GeE5zLWLmug4A-aINfY.jpg)
Plenary: Five People Changing the Face of Bioscience
![Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns](/sites/default/files/oembed_thumbnails/fi89OTIVaFa4ubTFsMDRQDqDZgu0YgJKVvfax5-VZ0g.jpg)
Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns
![Plenary: Big Data Needs Big Ideas](/sites/default/files/oembed_thumbnails/Juq-cVgw8-8_huRpZh1YCXCxZXOAHIfaWW8IcY4WsUM.jpg)
Plenary: Big Data Needs Big Ideas
![Panel: FDA: Recalibrating the Benefit-Risk Equation](/sites/default/files/oembed_thumbnails/0uWLuPyzzWz1J3zjH3dd2826RSFVX9FKeEwhBl_5m6o.jpg)
Panel: FDA: Recalibrating the Benefit-Risk Equation
![Panel - Learning to Love Failure](/sites/default/files/oembed_thumbnails/eo9vQOy4UiREd5NdFe02qp-4Cy77reEME_GyieHkvtw.jpg)
Panel - Learning to Love Failure
![Panel: Rare Diseases: Hot, but for How Long?](/sites/default/files/oembed_thumbnails/CDiChmT93G6GkSpDzQnTTfnQa9uBEyqpNHy-_8r5hrM.jpg)